195 related articles for article (PubMed ID: 32075595)
1. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
[TBL] [Abstract][Full Text] [Related]
4. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
5. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
[TBL] [Abstract][Full Text] [Related]
6. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
[TBL] [Abstract][Full Text] [Related]
7. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
[TBL] [Abstract][Full Text] [Related]
8. Aberrant crypt focus size predicts distal polyp histopathology.
Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
BMC Cancer; 2020 Aug; 20(1):770. PubMed ID: 32807113
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Smoking on the Number and Type of Rectal Aberrant Crypt Foci (ACF)-First Identifiable Precursors of Colorectal Cancer (CRC).
Kowalczyk M; Klepacki Ł; Zieliński E; Kurpiewski W; Zinkiewicz K; Dyśko Ł; Pesta W
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375262
[TBL] [Abstract][Full Text] [Related]
11. The natural history of aberrant crypt foci.
Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
[TBL] [Abstract][Full Text] [Related]
12. Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci.
Kowalczyk M; Siermontowski P; Mucha D; Ambroży T; Orłowski M; Zinkiewicz K; Kurpiewski W; Paśnik K; Kowalczyk I; Pedrycz A
PLoS One; 2016; 11(2):e0148286. PubMed ID: 26886097
[TBL] [Abstract][Full Text] [Related]
13. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
[TBL] [Abstract][Full Text] [Related]
14. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.
Figueiredo P; Donato M; Urbano M; Goulão H; Gouveia H; Sofia C; Leitão M; Freitas D
Int J Colorectal Dis; 2009 Apr; 24(4):441-50. PubMed ID: 18769883
[TBL] [Abstract][Full Text] [Related]
15. Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps.
Erichsen R; Baron JA; Hamilton-Dutoit SJ; Snover DC; Torlakovic EE; Pedersen L; Frøslev T; Vyberg M; Hamilton SR; Sørensen HT
Gastroenterology; 2016 Apr; 150(4):895-902.e5. PubMed ID: 26677986
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
[TBL] [Abstract][Full Text] [Related]
18. Colonic adenomas found via colonoscopy: yield and risk factors for high-grade dysplasia.
Kristjansdottir S; Jonasson JG; Cariglia N; Thjodleifsson B
Digestion; 2010; 82(4):252-7. PubMed ID: 20588041
[TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
